Answer
Ceritinib (Zykadia) is approved as monotherapy for adults with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer, either as first-line treatment or after previous treatment with crizotinib.
Sources for this answer
- Zykadia 150mg Film-coated TabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 3Document updated
Sources checked